Generic placeholder image

Coronaviruses

Author(s): Pugazhenthan Thangaraju*, Ku Krishna Verma, Hemasri Velmurugan, Himanshu Nirmal Chandu, Tulika Chakrabarti, Prasun Chakrabarti and Sajitha Venkatesan

DOI: 10.2174/2666796704666230815143020

DownloadDownload PDF Flyer Cite As
Analysis of Research Publication on Logistics at the Time of COVID-19: A Scientometric Study

Article ID: e150823219732 Pages: 6

  • * (Excluding Mailing and Handling)

Abstract

Coronaviruses have a wide range of health, mobility, and economic consequences. The Coronavirus pandemic is an unprecedented incident that has drawn the attention of the general public to supply chain management. It caused severe interruptions between 2020 and 2022. Despite the importance and size of the impact of coronaviruses on research performance across time, the literature on comprehensive coronavirus-related research performance is limited. This study aimed at a scientometric evaluation of bibliographic facts associated with the supply chain during the pandemic, and data related to it was extracted from PubMed between January 2020 and December 2022. The purpose of this research is to examine scientometric methods such as frequency distribution, percentage analysis, relative growth rate, doubling time, and degree of collaboration. We have obtained a total of 116 publications during this study period, and a maximum of 26 (22.4%) contributions were made in the months of May to August 2021. The relative growth rate is declining, and the doubling time is increasing between May to August 2021. Scientifically analysing and comprehending bibliographic facts associated with the supply chain during the COVID-19 pandemic as widely as possible can also assist society in being better prepared for future pandemic breakouts, ultimately supporting informed decision-making in light of societal values. The authors highly advocate the recent COVID-19 epidemic as a call for greater collaborative, worldwide research.

Graphical Abstract

[1]
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[2]
Murthy S, Gomersall CD, Fowler RA. Care for critically Ill patients with COVID-19. JAMA 2020; 323(15): 1499-500.
[http://dx.doi.org/10.1001/jama.2020.3633] [PMID: 32159735]
[3]
Naresh BV. A review of the 2019 novel coronavirus (COVID-19) pandemic. Asian J Pharmaceut Res 2020; 10(3): 233-8.
[4]
Chavhan AB, Jadhav PS, Shelke S. COVID 19: Outbreak, structure and current therapeutic strategies. Asian J Pharma Technol 2021; 11(1): 76-83.
[http://dx.doi.org/10.5958/2231-5713.2021.00013.1]
[5]
Shivom Goswami S, Pal N, Singh RP, Singh A. Kumudhavalli MV. A meticulous interpretation on a sanguinary disease COVID-19. Res J Pharm Dos Forms Technol 2020; 12(3): 231-3.
[http://dx.doi.org/10.5958/0975-4377.2020.00038.5]
[6]
Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group. BioRxiv 2020; 2020; 937862.
[http://dx.doi.org/10.1101/2020.02.07.937862]
[7]
Wankhede DK. COVID-19- problem faced by Indians during Lockdown. Asian J Nurs Edu Res 2020; 10(4): 501-4.
[http://dx.doi.org/10.5958/2349-2996.2020.00108.1]
[8]
Haghani M, Bliemer MCJ, Goerlandt F, Li J. The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review. Saf Sci 2020; 129: 104806.
[http://dx.doi.org/10.1016/j.ssci.2020.104806] [PMID: 32382213]
[9]
Shetty AD, Shetty A, Shetty J, Shenoy S, Sreedhar D, Nayak S. Pharma insurance: A mechanism for risk mitigation. Res J Pharma Technol 2021; 14(5): 2659-64.
[http://dx.doi.org/10.52711/0974-360X.2021.00469]
[10]
Supply chain. Investopedia. Available from: https://www.investopedia.com/terms/s/supplychain.asp (Accessed on: May. 13, 2022)
[11]
Croom S, Romano P, Giannakis M. Supply chain management: An analytical framework for critical literature review. Eur J Purchasing Supply Manag 2000; 6(1): 67-83.
[http://dx.doi.org/10.1016/S0969-7012(99)00030-1]
[12]
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109: 102433.
[http://dx.doi.org/10.1016/j.jaut.2020.102433] [PMID: 32113704]
[13]
Wieland A. Dancing the supply chain: Toward transformative supply chain management. J Supply Chain Manag 2021; 57(1): 58-73.
[http://dx.doi.org/10.1111/jscm.12248]
[14]
COVID-19 and the health care supply chain: Impacts and lessons learned. Available from: https://www.supplychainquarterly.com/articles/4417-covid-19-and-the-health-care-supply-chain-impacts-and-lessons-learned (Accessed on: May. 13, 2022)
[15]
Luo J, Liang Y, Bai Y. Mapping the intellectual structure of short food supply chains research: A bibliometric analysis. Br Food J 2022; 124(9): 2833-56.
[http://dx.doi.org/10.1108/BFJ-05-2021-0465]
[16]
Gupta S, Palsule-Desai OD. Sustainable supply chain management: Review and research opportunities. IIMB Manag Rev 2011; 23(4): 234-45.
[http://dx.doi.org/10.1016/j.iimb.2011.09.002]
[17]
Katsaliaki K, Galetsi P, Kumar S. Supply chain disruptions and resilience: A major review and future research agenda. Ann Oper Res 2021; 19(1): 1-38.
[PMID: 33437110]
[18]
COVID-19: Implications for business. Available from: https://www.mckinsey.com/business-functions/risk-and-resilience/our-insights/COVID-19-implications-for-business (Accessed on: May. 13, 2022)
[19]
LeMay S, Helms MM, Kimball B, McMahon D. Supply chain management: The elusive concept and definition. Int J Logist Manag 2017; 28(4): 1425-53.
[http://dx.doi.org/10.1108/IJLM-10-2016-0232]
[20]
Mehrotra S, Rahimian H, Barah M, Luo F, Schantz K. A model of supply‐chain decisions for resource sharing with an application to ventilator allocation to combat COVID ‐19. Nav Res Logist 2020; 67(5): 303-20.
[http://dx.doi.org/10.1002/nav.21905]
[21]
Messina D, Barros AC, Soares AL, Matopoulos A. An information management approach for supply chain disruption recovery. Int J Logist Manag 2020; 31(3): 489-519.
[http://dx.doi.org/10.1108/IJLM-11-2018-0294]
[22]
Pawar MS. Bibliometric: A research technique. Int J Adv Social Sci 2020; 8(3): 105-10.
[23]
Sahu HK. A bibliometric analysis of research journal ‘asian journal of management, 2010–2017’. Asian J Manag 2017; 8(4): 1242-6.
[http://dx.doi.org/10.5958/2321-5763.2017.00189.5]
[24]
Mahapatra M. On the validity of the theory of exponential growth of scientific literature. Proceedings of the 15th IASLIC conference. Bangalore. 1985; p. 6170.
[25]
Sivasamy K, Vivekanandhan S. Scientometrics analysis of leprosy research publications during 2009-2018 from Scopus database. Scientometrics 2020; 10(3): 1-0.
[26]
Vivekanandhan S, Sivasamy K. Growth of pollution control research publications In India from Scopus database (1991-2015): A scientometric study. E-Library Sci Res J 2017; 5(3): 1-9.
[27]
How COVID-19 impacted supply chains and what comes next. Available from: https://www.ey.com/en_gl/supply-chain/how-COVID-19-impacted-supply-chains-and-what-comes-next (Accessed on: May. 13, 2022)
[28]
Raj A, Mukherjee AA, de Sousa Jabbour ABL, Srivastava SK. Supply chain management during and post-COVID-19 pandemic: Mitigation strategies and practical lessons learned. J Bus Res 2022; 142: 1125-39.
[http://dx.doi.org/10.1016/j.jbusres.2022.01.037] [PMID: 35079190]
[29]
Govindan K, Mina H, Alavi B. A decision support system for demand management in healthcare supply chains considering the epidemic outbreaks: A case study of coronavirus disease 2019 (COVID-19). Transp Res, Part E Logist Trans Rev 2020; 138: 101967.
[http://dx.doi.org/10.1016/j.tre.2020.101967] [PMID: 32382249]
[30]
Craighead CW, Ketchen DJ Jr, Darby JL. Pandemics and supply chain management research: Toward a theoretical toolbox *. Decis Sci 2020; 51(4): 838-66.
[http://dx.doi.org/10.1111/deci.12468] [PMID: 34234384]
[31]
Building Resilient Supply Chains, Revitalizing American Manufacturing, And Fostering Broad-Based Growth. Available from: https://www.whitehouse.gov/wp-content/uploads/2021/06/100-day-supply-chain-review-report.pdf (Accessed on: May. 13, 2022)
[32]
Tang CS. Perspectives in supply chain risk management. Int J Prod Econ 2006; 103(2): 451-88.
[http://dx.doi.org/10.1016/j.ijpe.2005.12.006]
[33]
Nguyen NAT, Wang CN, Dang LTH, Dang LTT, Dang TT. Selection of cold chain logistics service providers based on a grey AHP and Grey COPRAS framework: A case study in vietnam. Axioms 2022; 11(4): 154.
[http://dx.doi.org/10.3390/axioms11040154]
[34]
Paul SK, Chowdhury P. A production recovery plan in manufacturing supply chains for a high-demand item during COVID-19. Int J Phys Distrib Logist Manag 2021; 51(2): 104-25.
[http://dx.doi.org/10.1108/IJPDLM-04-2020-0127]
[35]
Baker EL Jr, Potter MA, Jones DL, et al. The public health infrastructure and our nation’s health. Annu Rev Public Health 2005; 26(1): 303-18.
[http://dx.doi.org/10.1146/annurev.publhealth.26.021304.144647] [PMID: 15760291]
[36]
Rowan NJ, Laffey JG. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID-19) pandemic - Case study from the Republic of Ireland. Sci Total Environ 2020; 725: 138532.
[http://dx.doi.org/10.1016/j.scitotenv.2020.138532] [PMID: 32304970]
[37]
Abbas K, Afaq M, Ahmed Khan T, Song WC. A blockchain and machine learning-based drug supply chain management and recommendation system for smart pharmaceutical industry. Electronics 2020; 9(5): 852.
[http://dx.doi.org/10.3390/electronics9050852]
[38]
OECD Policy Responses to Coronavirus (COVID-19). Available from: https://www.oecd.org/coronavirus/policy-responses/the-territorial-impact-of-COVID-19-managing-the-crisis-and-recovery-across-levels-of-government-a2c6abaf/ (Accessed on: May. 13, 2022)
[39]
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395(10229): 1054-62.
[http://dx.doi.org/10.1016/S0140-6736(20)30566-3] [PMID: 32171076]
[40]
Malik AA, Butt NS, Bashir MA, Gilani SA. A scientometric analysis on coronaviruses research (1900–2020): Time for a continuous, cooperative and global approach. J Infect Public Health 2021; 14(3): 311-9.
[http://dx.doi.org/10.1016/j.jiph.2020.12.008] [PMID: 33618275]
[41]
Parast MM. The impact of R&D investment on mitigating supply chain disruptions: Empirical evidence from U.S. firms. Int J Prod Econ 2020; 227: 107671.
[http://dx.doi.org/10.1016/j.ijpe.2020.107671]
[42]
Shekarian M, Mellat Parast M. An Integrative approach to supply chain disruption risk and resilience management: A literature review. Int J Logist 2021; 24(5): 427-55.
[http://dx.doi.org/10.1080/13675567.2020.1763935]
[43]
Ponomarov SY, Holcomb MC. Understanding the concept of supply chain resilience. Int J Logist Manag 2009; 20(1): 124-43.
[http://dx.doi.org/10.1108/09574090910954873]
[44]
Rampal S, Rampal L, Jayaraj VJ, et al. The epidemiology of COVID-19 in ten Southeast Asian countries. Med J Malaysia 2021; 76(6): 783-91.
[PMID: 34806661]